Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government ...

The task force is a critical advisory body to HHS, reviewing scientific evidence to provide recommendations on whether ...

Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over ...